Dr. Reddy’s and Nestlé Health Science Strengthens Presence in Diabetes & Obesity Nutrition Space with Celevida® GLP+ Launch
Studies indicate that GLP-1/GIP therapies may lead to lean body mass loss (25–40% of total weight reduction) Also, Indian patients could be potentially at higher...